DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RAVIDASVIR

« Back to Dashboard

Clinical Trials for Ravidasvir

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02371408	A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4	Active, not recruiting	Pharco Pharmaceuticals	Phase 2/Phase 3	The study will assess the efficacy of PPI-668 (USAN: ravidasvir hydrochloride) in combination with sofosbuvir, with or without ribavirin, in the following Egyptian HCV gt-4 patient populations: 1. Treatment-naïve patients, with and without cirrhosis (Group 1) 2. Previous non-responders to interferon-based therapies, without cirrhosis (Group 2) 3. Previous non-responders to interferon-based therapies, with cirrhosis (Group 3)
NCT02961426	Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection	Recruiting	Ministry of Health, Malaysia	Phase 2/Phase 3	This is a Phase II/III, multicenter, multi-country, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir for the treatment of HCV infection.
NCT02961426	Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection	Recruiting	Drugs for Neglected Diseases	Phase 2/Phase 3	This is a Phase II/III, multicenter, multi-country, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir for the treatment of HCV infection.
NCT03020095	Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan	Active, not recruiting	Ascletis Pharmaceuticals Co., Ltd.	Phase 2	The purpose of this study is to evaluate the efficacy, safety and tolerability of Ravidasvir (ASC16) in combination with Ritonavir-boosted Danoprevir(ASC08) and Ribavirin in treatment-naive no-cirrhotic Taiwanese patients who have chronic hepatitis C genotype1.

Clinical Trial Conditions for Ravidasvir

Condition Name

Condition Name for
Intervention	Trials
Chronic Hepatitis c	3
Healthy	3
HCV	1
Bioequivalence Study	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Hepatitis C	4
Hepatitis, Chronic	3
Hepatitis C, Chronic	3
Hepatitis	2

Clinical Trial Locations for Ravidasvir

Trials by Country

Trials by Country for
Location	Trials
China	4
Malaysia	2
Thailand	1
Egypt	1

Clinical Trial Progress for Ravidasvir

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 2/Phase 3	3
Phase 2	1
Phase 1	5

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Recruiting	4
Active, not recruiting	4
Completed	1

Clinical Trial Sponsors for Ravidasvir

Sponsor Name

Sponsor Name for
Sponsor	Trials
Ascletis Pharmaceuticals Co., Ltd.	6
Drugs for Neglected Diseases	2
Ministry of Health, Malaysia	1

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	7
Other	3